创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

环泊酚麻醉诱导对脑动脉瘤介入栓塞术患者呼吸循环、应激反应及免疫功能的影响

Effect of Ciprofol for Anesthesia Induction on Respiratory and Circulatory Parameters, Stress Response, and Immune Function in Patients Undergoing Interventional Embolization for Cerebral Aneurysms

  • 摘要: 目的 探讨环泊酚麻醉诱导应用于脑动脉瘤介入栓塞术对患者呼吸循环、应激、免疫功能的影响。方法 按照随机数字表法将南京脑科医院2024年1月至2025年1月收治的106例拟行介入栓塞术治疗的脑动脉瘤患者分为2组,其中环泊酚组(n=53)麻醉诱导药物选择环泊酚,对照组(n=53)麻醉诱导药物选择丙泊酚中/长链脂肪乳。记录2组患者的呼吸循环、应激反应和免疫功能指标变化,以及麻醉恢复情况。结果 环泊酚组的呼吸循环指标未见明显波动(P > 0.05)。对照组麻醉诱导10 min、手术开始30 min时的血氧饱和度、平均动脉压低于麻醉诱导前和环泊酚组,心率快于麻醉诱导前和环泊酚组,麻醉诱导10 min时的收缩压(systolicblood pressure,SBP)、舒张压(diastolic blood pressure,DBP)低于麻醉诱导前和环泊酚组,手术开始30 min时的SBP、DBP高于麻醉诱导前和环泊酚组(P < 0.05)。环泊酚组术后自主呼吸恢复时间、睁眼时间和拔管时间早于对照组,麻醉后恢复室停留时间较对照组更短(P < 0.05)。手术结束时,2组超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶,以及CD3+、CD4+和CD4+/CD8+较麻醉诱导前下降(P < 0.05),而环泊酚组较对照组更高(P < 0.05)。结论 相较于丙泊酚,脑动脉瘤栓塞术麻醉诱导时使用环泊酚能更有效地维持术中呼吸循环稳定,减少应激、免疫功能波动,带来更高的苏醒质量。

     

    Abstract: Objective To investigate the effect of ciprofol for anesthesia induction on respiratory and circulatory parameters, stress response, and immune function in patients undergoing interventional embolization for cerebral aneurysms. Methods A total of 106 patients scheduled for interventional embolization of cerebral aneurysms at Nanjing Brain Hospital from January 2024 to January 2025 were enrolled and randomly divided into two groups using a random number table method. In the ciprofol group (n= 53), patients received ciprofol for anesthesia induction, while in the control group (n= 53), patients received propofol medium/long-chain fat emulsion. Changes in respiratory and circulatory parameters, stress response and immune function markers, as well as anesthesia recovery, were recorded and compared between the two groups. Results No significant fluctuations in respiratory and circulatory parameters were observed in the ciprofol group (P > 0.05). In the control group, oxygen saturation (SpO2) and mean arterial pressure (MAP) at 10 minutes after induction and 30 minutes after surgery onset were lower than those before induction and lower than those in the ciprofol group, while heart rate (HR) was higher (P < 0.05). At 10 minutes post-induction, systolic blood pressure (SBP) and diastolic blood pressure (DBP) in the control group were also lower than pre-induction levels and those in the ciprofol group. At 30 minutes after surgery onset, both SBP and DBP in the control group were higher than pre-induction values and those in the ciprofol group (P < 0.05). The time to spontaneous respiration recovery, eye opening, and extubation were earlier in the ciprofol group than in the control group, and the post-anesthesia care unit stay was shorter (P < 0.05). At the end of surgery, both groups showed reductions in superoxide dismutase, catalase, glutathione peroxidase, as well as CD3+, CD4+ levels and the CD4+/CD8+ ratio compared to pre-induction levels (P < 0.05), but these values were higher in the ciprofol group than in the control group (P < 0.05). Conclusion Compared with propofol, using ciprofol for anesthesia induction in cerebral aneurysm embolization can more effectively maintain intraoperative respiratory and circulatory stability, reduce fluctuations in stress and immune function, and provide better quality of recovery.

     

/

返回文章
返回